Literature DB >> 24345665

Metabolic syndrome predicts the incidence of hepatic steatosis in Koreans.

Kayoung Lee1.   

Abstract

PROBLEM: It has not been well elucidated whether the development of metabolic syndrome and its components predicts the incidence of hepatic steatosis.
METHODS: A cohort of 1705 apparently healthy Korean adults (954 men and 751 women, 43.6 ± 8.5 years old) without ultrasonographically defined hepatic steatosis and with normal serum gamma-glutamyl-transpeptidase and alanine aminotransferase was followed from 2004 to 2007. Metabolic syndrome was defined as the presence of at least three of the following components: obesity (BMI ≥ 25.0 kg/m(2)), high blood pressure, elevated levels of triglycerides and fasting glucose, and low level of high-density lipoprotein cholesterol. The outcome was ultrasonographically diagnosed hepatic steatosis. The analyses were conducted using the Cox proportional hazards model and time-dependent Cox model.
RESULTS: A total of 226 individuals developed hepatic steatosis during 3716 person-years of follow-up. The presence of one to two metabolic syndrome components at baseline significantly predicted the development of hepatic steatosis. Metabolic syndrome itself, having ≥1 metabolic syndrome components, and maintenance of metabolic syndrome during follow-up significantly increased the risk (hazard ratio 2.0-4.1 for men, 3.4-10.8 for women) after adjustment for the follow-up period, age and BMI at baseline or updated during follow-up. Occurrence of obesity, high triglycerides or high fasting glucose during follow-up significantly predicted the development of hepatic steatosis, even after adjustment for metabolic syndrome components at baseline.
CONCLUSIONS: The presence at baseline and the development of metabolic syndrome during follow-up were risk factors for ultrasonographically detected hepatic steatosis. Â
© 2010 Asian Oceanian Association for the Study of Obesity . Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2010        PMID: 24345665     DOI: 10.1016/j.orcp.2010.02.004

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  3 in total

1.  A study of gender-wise risk association between fatty liver and metabolic syndrome components (Asia-Pacific criteria) in a South Indian urban cohort.

Authors:  M Srinivas; Vijaya Srinivasan; Madhu Bashini Mohan; Joy Varghese; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2015-01-11

2.  γ-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly.

Authors:  Dee Pei; Te-Lin Hsia; Ting-Ting Chao; Jiunn-Diann Lin; Chun-Hsien Hsu; Chung-Ze Wu; Chang-Hsun Hsieh; Yao-Jen Liang; Yen-Lin Chen
Journal:  Saudi J Gastroenterol       Date:  2015 May-Jun       Impact factor: 2.485

3.  Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico.

Authors:  Yvonne N Flores; Aryana T Amoon; Baolong Su; Rafael Velazquez-Cruz; Paula Ramírez-Palacios; Jorge Salmerón; Berenice Rivera-Paredez; Janet S Sinsheimer; Aldons J Lusis; Adriana Huertas-Vazquez; Sammy Saab; Beth A Glenn; Folasade P May; Kevin J Williams; Roshan Bastani; Steven J Bensinger
Journal:  Lipids Health Dis       Date:  2021-10-10       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.